Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.
about
The management of gestational diabetesInterconception care for women with a history of gestational diabetes for improving maternal and infant outcomesInterconception care for women with a history of gestational diabetes for improving maternal and infant outcomesOral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitusOral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitusMetformin in gestational diabetes: An emerging contenderPrenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthoodDysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement.Pharmacokinetics of metformin during pregnancy.Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis.Impact of metformin on reproductive tissues: an overview from gametogenesis to gestationFirst-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?Management of gestational diabetes mellitus.Metformin vs insulin in the management of gestational diabetes: a meta-analysis.Use of oral anti-diabetic agents in pregnancy: a pragmatic approachThe Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy.Gestational diabetes mellitus: Non-insulin management.Insulin-sensitisers in the treatment of polycystic ovary syndrome.Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?Contemporary medical therapy for polycystic ovary syndrome.Insulins and oral hypoglycemic agents in pregnancy.Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?Metformin before and during pregnancy and lactation in polycystic ovary syndrome.AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat.Treating the mother--protecting the unborn: the safety of hypoglycemic drugs in pregnancy.Management of Type 2 diabetes and pregnancy.Oral hypoglycemic agents for gestational diabetes mellitus?The use of oral hypoglycaemic agents in pregnancy.Safety considerations with pharmacological treatment of gestational diabetes mellitus.Polycystic ovary syndrome and insulin: our understanding in the past, present and future.Comparison of glyburide with metformin in treating gestational diabetes mellitus: a systematic review and meta-analysis.Metformin exposure affects human and mouse fetal testicular cells.Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome.Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes.Metformin Treatment Does Not Affect Testicular Size in Offspring Born to Mothers with Gestational Diabetes.Metformin compared with glyburide for the management of gestational diabetes.Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy.
P2860
Q22241441-425F283D-8674-4DFA-84D3-F06927ADF05CQ24197906-0FF7986C-D3F8-4F83-B7F7-048B017FE561Q24202188-D733BDFA-276F-4D29-B1A3-C43D3B88FEB6Q24234519-75BA0CF7-D11E-41B6-A738-5A3BBBFC2344Q24240792-262F02F9-0218-47D1-81F5-6B9E42EB523CQ28082051-F1C5CC73-ADD4-4A57-A63E-C137505FA322Q28486189-0EE971A0-562E-431C-85F7-C5837500D206Q33842357-70752359-7497-4162-AF86-820CD743F1E1Q33861891-115FE74C-66DA-4319-958C-E70DF632519CQ34323577-B807D099-2BAC-4CB4-8305-BF8A738DF843Q34357928-AB6049B0-EF55-4F89-A248-81D371F40D18Q34421386-83BC68E1-61EB-4F00-A080-BABD83410B70Q34579835-63439138-8CDB-44F5-B9BC-CAC7778E31B8Q34620699-2FCF8FCB-2E0E-4F70-9286-452FBC5737E6Q34749641-34548FB7-FAF2-4E13-8386-1BD7A8ED2E3FQ35075843-02DA7913-03D1-410E-9A73-1425042BB60CQ35100131-AFC901F3-CC7D-4275-9661-35D393AA9C67Q35271334-4A367403-3727-4C01-8FEB-0386C1F577B0Q35352513-C0020C06-F626-4094-BF41-D34B49EA5100Q36301573-6BE0EA0D-4167-4E2A-B123-6238B033328AQ36402610-1DBE2817-65E0-4371-983D-FA2902D70CE8Q36608161-2EC52E11-B9FE-4425-A0B1-4AEB157DB46EQ36664808-D6FA9141-762F-43A0-BCA6-71068715D393Q36673559-3A6CDB04-E770-4964-85D5-42A2BF8F60D2Q36762451-1DDDF1F9-76F6-45D5-B1B7-FAC98F6AFC46Q36764442-6D69447E-36BE-4D07-B2E8-F69C2F1CA1E7Q37093704-62941DE8-2542-460E-9AB7-C45ED9BBD333Q37608444-95608933-214C-4F07-8FF6-F6AF0304BEA8Q37826425-825DB4D8-F3AA-4113-BA6E-FC87E1B440E5Q38188053-2FA5085F-7518-412A-97B7-7BA66F1FAB56Q38301238-D15ECD67-661F-4A12-AEF8-644D4C68A041Q38380065-6E1784EB-1E50-4A47-BFBF-DACF8E280130Q38488606-9FFD4D79-DA82-4B5E-BF0D-B2572A057771Q39583558-9FCC4E54-8990-4DB2-9E95-6D053D902CC2Q39754625-CA0E66B6-AD14-44B8-90C1-4EE49D609715Q39971043-E2E60DCC-2C9E-4FC7-8674-7E5C6B9CA970Q41690290-E0F5C0CB-E7EA-4EB6-B7EB-F516E1F8F77DQ43028047-EBBD6CC3-253B-4258-8CAD-81B81E217738Q43229974-5B704EF5-D808-4DFF-9FD6-4B2C7B9C91D5Q43878359-56D348C9-E104-407B-86DA-70C318546867
P2860
Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Height, weight, and motor-soci ...... d metformin through pregnancy.
@ast
Height, weight, and motor-soci ...... d metformin through pregnancy.
@en
Height, weight, and motor-soci ...... d metformin through pregnancy.
@nl
type
label
Height, weight, and motor-soci ...... d metformin through pregnancy.
@ast
Height, weight, and motor-soci ...... d metformin through pregnancy.
@en
Height, weight, and motor-soci ...... d metformin through pregnancy.
@nl
prefLabel
Height, weight, and motor-soci ...... d metformin through pregnancy.
@ast
Height, weight, and motor-soci ...... d metformin through pregnancy.
@en
Height, weight, and motor-soci ...... d metformin through pregnancy.
@nl
P2093
P356
P1433
P1476
Height, weight, and motor-soci ...... d metformin through pregnancy.
@en
P2093
P304
P356
10.1093/HUMREP/DEH263
P407
P577
2004-04-29T00:00:00Z